SPRO / Spero Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Spero Therapeutics, Inc.
US ˙ NasdaqGS ˙ US84833T1034

Deler fremragende 57,901,493 shares
Insideraktier24.221.074 shares
Insider ejerskab41,83 %
Total Insiders28
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-1 ( )
9440 out of 10916

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-0.054% ( )
9877 out of 10752

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Spero Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Aquilo Capital Management, LLC 10% Owner - [10%] 3.419.435 3.419.435
Aquilo Capital, L.P. 10% Owner - [10%] 5.321.231 3.419.435
Atlas Venture Associates IX, L.P. 10% Owner - [10%] 85.562 85.562
Atlas Venture Associates IX, LLC 10% Owner - [10%] 85.562 85.562
Atlas Venture Fund IX, L.P. 10% Owner - [10%] 85.562 85.562
Casper Breum Director - [D] 1.091.774 1.091.774
Milind Deshpande Director - [D] 91.454 91.454
DiPalma Stephen J. 0
Jean Francois Formela Director - [D] 2.408.128 2.408.128
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Plc Glaxosmithkline 10% Owner - [10%] 9.190.606 9.190.606
Vikas Goyal Director - [D] 1.854.006 1.854.006
Kamal Hamed Chief Medical Officer - [O] 788.117 788.117
Tamara L Joseph Chief Legal Officer - [O] 531.615 531.615
Scott Thomas Jackson Director - [D] 75.000 75.000
Timothy Keutzer Chief Operating Officer - [O] 742.506 742.506
Cristina Larkin Chief Operating Officer - [O] 63.581 63.581
Ankit Mahadevia Director - [D] 703.294 703.294
Melnick David A. Chief Medical Officer - [O] 62.081 62.081
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Thomas R JR Parr 35.000
John C Jr Pottage Director - [D] 75.000 75.000
Esther Rajavelu See Remarks - [O] 986.851 986.851
David P Southwell 6.073
Joel Sendek Chief Financial Officer - [O] 15.181 15.181
Sath Shukla CEO & President - [O] 1.736.883 1.736.883
Cynthia Smith Director - [D] 75.000 75.000
Frank E Thomas Director - [D] 75.000 75.000
Kathleen Tregoning Director - [D] 75.000 75.000
Vink Patrick V.j.j. Director - [D] 75.000 75.000

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SPRO / Spero Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-04-26 Aquilo Capital Management, LLC 39.727 5,2350 39.727 5,2350 207.971 0 5.2500 597 0,29
2022-03-30 Aquilo Capital Management, LLC 33.115 8,7884 33.115 8,7884 291.028
2022-03-30 Aquilo Capital Management, LLC 16.885 8,7884 16.885 8,7884 148.392
2022-03-14 Aquilo Capital Management, LLC 15.702 7,6260 15.702 7,6260 119.743
2022-03-14 Aquilo Capital Management, LLC 8.006 7,6260 8.006 7,6260 61.054
2022-02-28 Aquilo Capital Management, LLC 29.729 9,5293 29.729 9,5293 283.297
2022-02-28 Aquilo Capital Management, LLC 15.104 9,5293 15.104 9,5293 143.931
2022-02-18 Aquilo Capital Management, LLC 14.828 9,2419 14.828 9,2419 137.039
2022-01-31 Aquilo Capital Management, LLC 125.000 11,5861 125.000 11,5861 1.448.262

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SPRO / Spero Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SPRO / Spero Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-05-04 Rajavelu Esther 25.240 2,5100 25.240 2,5100 63.352 1 2.4200 -2.271 -3,59
2026-02-06 Keutzer Timothy 18.652 2,3600 18.652 2,3600 44.019
2026-02-06 Rajavelu Esther 37.101 2,3600 37.101 2,3600 87.558
2026-02-06 Rajavelu Esther 50.816 2,3600 50.816 2,3600 119.926
2026-02-04 Keutzer Timothy 3.471 2,2400 3.471 2,2400 7.775
2026-02-03 Keutzer Timothy 24.224 2,1400 24.224 2,1400 51.839
2026-02-02 Keutzer Timothy 18.891 2,2000 18.891 2,2000 41.560
2026-02-02 Rajavelu Esther 18.442 2,2000 18.442 2,2000 40.572
2025-11-07 Rajavelu Esther 40.270 2,3700 40.270 2,3700 95.440

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SPRO / Spero Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-05-06 2026-05-04 4 Rajavelu Esther SPRO Common Stock S - Sale D 2,5100 -25.240 -63 986.851
2026-02-09 2026-02-06 4 Rajavelu Esther SPRO Common Stock S - Sale D 2,3600 -50.816 -120 1.012.091
2026-02-09 2026-02-06 4 Rajavelu Esther SPRO Common Stock S - Sale D 2,3600 -37.101 -88 1.062.907
2026-02-09 2026-02-06 4 Keutzer Timothy SPRO Common Stock S - Sale D 2,3600 -18.652 -44 742.506
2026-02-05 2026-02-04 4 Keutzer Timothy SPRO Common Stock S - Sale D 2,2400 -3.471 -8 761.158
2026-02-05 2026-02-03 4 Keutzer Timothy SPRO Common Stock S - Sale D 2,1400 -24.224 -52 764.629
2026-02-05 2026-02-02 4 Keutzer Timothy SPRO Common Stock S - Sale D 2,2000 -18.891 -42 788.853
2026-02-05 2026-02-02 4 Keutzer Timothy SPRO Common Stock A - Award D 68.000 807.744
2026-02-04 2026-02-02 4 Rajavelu Esther SPRO Common Stock S - Sale D 2,2000 -18.442 -41 1.100.008
2026-02-04 2026-02-02 4 Rajavelu Esther SPRO Common Stock A - Award D 249.000 1.118.450
2025-11-12 2025-11-07 4 Rajavelu Esther SPRO Common Stock S - Sale D 2,3700 -40.270 -95 869.450
2025-09-03 2025-08-28 4 Keutzer Timothy SPRO Common Stock S - Sale D 1,9700 -1.695 -3 739.744
2025-09-03 2025-08-28 4 Mahadevia Ankit SPRO Common Stock S - Sale D 1,9700 -6.572 -13 703.294
2025-06-16 2025-06-12 4 Mahadevia Ankit SPRO Common Stock A - Award D 20.000 709.866
2025-06-16 2025-06-12 4 Deshpande Milind SPRO Common Stock A - Award D 20.000 91.454
2025-06-16 2025-06-12 4 Jackson Scott Thomas SPRO Common Stock A - Award D 20.000 75.000
2025-06-16 2025-06-12 4 VINK PATRICK V.J.J. SPRO Common Stock A - Award D 20.000 75.000
2025-06-16 2025-06-12 4 Pottage John C Jr SPRO Common Stock A - Award D 20.000 75.000
2025-06-16 2025-06-12 4 THOMAS FRANK E SPRO Common Stock A - Award D 20.000 75.000
2025-06-16 2025-06-12 4 Smith Cynthia SPRO Common Stock A - Award D 20.000 75.000
2025-06-16 2025-06-12 4 Tregoning Kathleen SPRO Common Stock A - Award D 20.000 75.000
2025-05-06 2025-05-02 4 Rajavelu Esther SPRO Common Stock A - Award D 185.000 909.720
2025-02-05 2025-02-05 4 Keutzer Timothy SPRO Common Stock S - Sale D 0,7800 -24.920 -19 741.439
2025-02-05 2025-02-05 4 Keutzer Timothy SPRO Common Stock S - Sale D 0,7800 -27.643 -22 766.359
2025-02-05 2025-02-05 4 Keutzer Timothy SPRO Common Stock S - Sale D 0,7800 -3.974 -3 794.002
2025-02-05 2025-02-03 4 Keutzer Timothy SPRO Common Stock A - Award D 266.139 797.976
2025-02-05 2025-02-05 4 Rajavelu Esther SPRO Common Stock S - Sale D 0,7800 -20.689 -16 724.720
2025-02-05 2025-02-03 4 Rajavelu Esther SPRO Common Stock A - Award D 100.000 745.409
2025-02-05 2025-02-03 4 Rajavelu Esther SPRO Common Stock A - Award D 266.139 645.409
2025-02-05 2025-02-05 4 Shukla Sath SPRO Common Stock S - Sale D 0,7800 -106.408 -83 1.736.883
2025-02-05 2025-02-05 4 Shukla Sath SPRO Common Stock S - Sale D 0,7800 -42.786 -33 1.843.291
2025-02-05 2025-02-05 4 Shukla Sath SPRO Common Stock S - Sale D 0,7800 -6.139 -5 1.886.077
2025-02-05 2025-02-03 4 Shukla Sath SPRO Common Stock A - Award D 751.407 1.892.216
2025-02-05 2025-02-05 4 Mahadevia Ankit SPRO Common Stock S - Sale D 0,7800 -55.260 -43 689.866
2025-02-05 2025-02-05 4 Mahadevia Ankit SPRO Common Stock S - Sale D 0,7800 -13.959 -11 745.126
2024-11-12 2024-11-08 4 Rajavelu Esther SPRO Common Stock S - Sale D 1,3000 -17.245 -22 379.270
2024-11-12 2024-11-07 4 Rajavelu Esther SPRO Common Stock S - Sale D 1,3100 -23.351 -31 396.515
2024-08-29 2024-08-27 4 Mahadevia Ankit SPRO Common Stock S - Sale D 1,3500 -5.912 -8 759.085
2024-08-29 2024-08-27 4 Keutzer Timothy SPRO Common Stock S - Sale D 1,3500 -2.213 -3 531.837
2024-08-29 2024-08-27 4 Shukla Sath SPRO Common Stock S - Sale D 1,3500 -2.757 -4 1.140.809
2024-08-06 2024-08-05 4 Shukla Sath SPRO Common Stock S - Sale D 1,3100 -17.641 -23 1.143.566
2024-08-06 2024-08-02 4 Shukla Sath SPRO Common Stock S - Sale D 1,3200 -14.800 -20 1.161.207
2024-05-30 2024-05-29 4 Deshpande Milind SPRO Common Stock A - Award D 20.000 71.454
2024-05-30 2024-05-29 4 Mahadevia Ankit SPRO Common Stock A - Award D 20.000 764.997
2024-05-30 2024-05-29 4 Jackson Scott Thomas SPRO Common Stock A - Award D 20.000 55.000
2024-05-30 2024-05-29 4 THOMAS FRANK E SPRO Common Stock A - Award D 20.000 55.000
2024-05-30 2024-05-29 4 Pottage John C Jr SPRO Common Stock A - Award D 20.000 55.000
2024-05-30 2024-05-29 4 Smith Cynthia SPRO Common Stock A - Award D 20.000 55.000
2024-05-30 2024-05-29 4 Tregoning Kathleen SPRO Common Stock A - Award D 20.000 55.000
2024-05-30 2024-05-29 4 VINK PATRICK V.J.J. SPRO Common Stock A - Award D 20.000 55.000
2024-02-05 2024-02-02 4 Keutzer Timothy SPRO Common Stock S - Sale D 1,3600 -30.971 -42 534.050
2024-02-05 2024-02-01 4 Keutzer Timothy SPRO Common Stock A - Award D 239.731 565.021
2024-02-05 2024-02-02 4 Mahadevia Ankit SPRO Common Stock S - Sale D 1,3700 -63.795 -87 744.997
2024-02-05 2024-02-02 4 JOSEPH TAMARA L SPRO Common Stock S - Sale D 1,3700 -30.906 -42 531.615
2024-02-05 2024-02-01 4 JOSEPH TAMARA L SPRO Common Stock A - Award D 239.731 562.521
2024-02-05 2024-02-02 4 HAMED KAMAL SPRO Common Stock S - Sale D 1,3700 -28.075 -38 788.117
2024-02-05 2024-02-01 4 HAMED KAMAL SPRO Common Stock A - Award D 239.731 816.192
2024-02-05 2024-02-01 4 Rajavelu Esther SPRO Common Stock A - Award D 119.866 419.866
2024-02-05 2024-02-05 4 Shukla Sath SPRO Common Stock S - Sale D 1,4500 -45.093 -65 1.176.007
2024-02-05 2024-02-02 4 Shukla Sath SPRO Common Stock S - Sale D 1,3700 -30.901 -42 1.221.100
2024-02-05 2024-02-01 4 Shukla Sath SPRO Common Stock A - Award D 679.501 1.252.001
2023-11-15 2023-11-13 4 Rajavelu Esther SPRO Common Stock A - Award D 300.000 300.000
2023-10-10 2023-10-05 4 Pottage John C Jr SPRO Common Stock A - Award D 20.000 35.000
2023-10-10 2023-10-05 4 THOMAS FRANK E SPRO Common Stock A - Award D 20.000 35.000
2023-10-10 2023-10-05 4 Smith Cynthia SPRO Common Stock A - Award D 20.000 35.000
2023-10-10 2023-10-05 4 Deshpande Milind SPRO Common Stock A - Award D 20.000 51.454
2023-10-10 2023-10-05 4 Tregoning Kathleen SPRO Common Stock A - Award D 20.000 35.000
2023-10-10 2023-10-05 4 VINK PATRICK V.J.J. SPRO Common Stock A - Award D 20.000 35.000
2023-10-10 2023-10-05 4 Jackson Scott Thomas SPRO Common Stock A - Award D 20.000 35.000
2023-10-10 2023-10-05 4 Mahadevia Ankit SPRO Common Stock A - Award D 20.000 808.792
2023-09-15 2023-09-13 4 HAMED KAMAL SPRO Common Stock S - Sale D 1,2700 -39.496 -50 576.461
2023-08-30 2023-08-29 4 Shukla Sath SPRO Common Stock S - Sale D 1,3000 -4.163 -5 572.500
2023-08-30 2023-08-28 4 Shukla Sath SPRO Common Stock S - Sale D 1,2600 -1.854 -2 576.663
2023-08-30 2023-08-28 4 Mahadevia Ankit SPRO Common Stock S - Sale D 1,2600 -9.040 -11 788.792
2023-08-30 2023-08-28 4 JOSEPH TAMARA L SPRO Common Stock S - Sale D 1,2600 -1.854 -2 322.790
2023-08-30 2023-08-28 4 Keutzer Timothy SPRO Common Stock S - Sale D 1,2600 -1.854 -2 325.290
2023-08-03 2023-08-01 4 Shukla Sath SPRO Common Stock A - Award D 266.000 578.517
2023-06-14 2023-06-12 4 HAMED KAMAL SPRO Common Stock A - Award D 140.000 615.957
2023-02-06 2023-02-03 4 Mahadevia Ankit SPRO Common Stock S - Sale D 1,8100 -12.286 -22 797.832
2023-02-03 2023-02-02 4 JOSEPH TAMARA L SPRO Common Stock S - Sale D 1,8600 -3.394 -6 324.644
2023-02-03 2023-02-01 4 JOSEPH TAMARA L SPRO Common Stock A - Award D 265.957 328.038
2023-02-03 2023-02-02 4 Keutzer Timothy SPRO Common Stock S - Sale D 1,8600 -3.394 -6 327.144
2023-02-03 2023-02-01 4 Keutzer Timothy SPRO Common Stock A - Award D 265.957 330.538
2023-02-03 2023-02-02 4 Shukla Sath SPRO Common Stock S - Sale D 1,8279 -9.504 -17 312.517
2023-02-03 2023-02-01 4 Shukla Sath SPRO Common Stock A - Award D 265.957 322.021
2023-02-03 2023-02-01 4 HAMED KAMAL SPRO Common Stock A - Award D 265.957 475.957
2023-02-03 2023-02-01 4 Mahadevia Ankit SPRO Common Stock A - Award D 531.914 810.118
2022-11-14 3 GLAXOSMITHKLINE PLC SPRO Common Stock I 9.190.606
2022-09-26 2022-09-22 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value S - Sale I 2,2503 -566.284 -1.274 3.419.435
2022-09-26 2022-09-22 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value S - Sale I 2,2503 -1.335.512 -3.005 3.985.719
2022-09-19 2022-09-15 4 Deshpande Milind SPRO Common Stock A - Award D 15.000 31.454
2022-09-19 2022-09-15 4 Jackson Scott Thomas SPRO Common Stock A - Award D 15.000 15.000
2022-09-19 2022-09-15 4 Smith Cynthia SPRO Common Stock A - Award D 15.000 15.000
2022-09-19 2022-09-15 4 Pottage John C Jr SPRO Common Stock A - Award D 15.000 15.000
2022-09-19 2022-09-15 4 THOMAS FRANK E SPRO Common Stock A - Award D 15.000 15.000
2022-09-19 2022-09-15 4 Tregoning Kathleen SPRO Common Stock A - Award D 15.000 15.000
2022-09-19 2022-09-15 4 VINK PATRICK V.J.J. SPRO Common Stock A - Award D 15.000 15.000
2022-09-14 2022-09-12 4 HAMED KAMAL SPRO Common Stock A - Award D 210.000 210.000
2022-08-30 2022-08-29 4 Shukla Sath SPRO Common Stock S - Sale D 0,8938 -6.017 -5 56.064
2022-04-28 2022-04-26 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 5,2350 39.727 208 5.321.231
2022-03-31 2022-03-30 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 8,7884 16.885 148 5.281.504
2022-03-31 2022-03-30 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 8,7884 33.115 291 5.264.619
2022-03-16 2022-03-14 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 7,6260 8.006 61 5.231.504
2022-03-16 2022-03-14 4 Aquilo Capital Management, LLC See footnotes SPRO Common Stock, $0.001 par value P - Purchase I 7,6260 15.702 120 5.223.498
2022-03-02 2022-02-28 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 9,5293 15.104 144 5.207.796
2022-03-02 2022-02-28 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 9,5293 29.729 283 5.192.692
2022-02-23 2022-02-18 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 9,2419 14.828 137 5.162.963
2022-02-03 2022-02-01 4 Larkin Cristina SPRO Stock Option (Right to Buy) A - Award D 11,18 53.190 53.190
2022-02-03 2022-02-01 4 Larkin Cristina SPRO Common Stock A - Award D 38.014 63.581
2022-02-03 2022-02-01 4 Shukla Sath SPRO Stock Option (Right to Buy) A - Award D 11,18 53.190 53.190
2022-02-03 2022-02-01 4 Shukla Sath SPRO Common Stock A - Award D 38.014 62.081
2022-02-03 2022-02-01 4 Melnick David A. SPRO Stock Option (Right to Buy) A - Award D 11,18 53.190 53.190
2022-02-03 2022-02-01 4 Melnick David A. SPRO Common Stock A - Award D 38.014 62.081
2022-02-03 2022-02-01 4 JOSEPH TAMARA L SPRO Stock Option (Right to Buy) A - Award D 11,18 53.190 53.190
2022-02-03 2022-02-01 4 JOSEPH TAMARA L SPRO Common Stock A - Award D 38.014 62.081
2022-02-03 2022-02-01 4 Keutzer Timothy SPRO Stock Option (Right to Buy) A - Award D 11,18 53.190 53.190
2022-02-03 2022-02-01 4 Keutzer Timothy SPRO Common Stock A - Award D 38.014 64.581
2022-02-03 2022-02-01 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) A - Award D 11,18 187.730 187.730
2022-02-03 2022-02-01 4 Mahadevia Ankit SPRO Common Stock A - Award D 134.168 278.204
2022-02-01 2022-01-31 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 11,5861 125.000 1.448 5.148.135
2022-01-26 2022-01-24 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 10,8931 1.599 17 5.023.135
2022-01-20 2022-01-18 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 12,4147 48.488 602 5.021.536
2022-01-12 2022-01-10 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 12,9253 8.867 115 4.973.048
2022-01-07 2022-01-05 4 Tregoning Kathleen SPRO Stock Option (Right to Buy) A - Award D 13,19 9,0300 4.428 40 4.428
2022-01-07 2022-01-05 4 THOMAS FRANK E SPRO Stock Option (Right to Buy) A - Award D 13,19 9,0300 2.214 20 2.214
2022-01-07 2022-01-05 4 VINK PATRICK V.J.J. SPRO Stock Option (Right to Buy) A - Award D 13,19 9,0300 2.214 20 2.214
2022-01-03 2021-12-31 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 15,7522 125.000 1.969 4.964.181
2022-01-03 2021-12-30 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 15,7722 50.000 789 4.839.181
2022-01-03 2021-12-29 4 Aquilo Capital Management, LLC See footnotes SPRO Common Stock, $0.001 par value P - Purchase I 14,6406 75.493 1.105 4.789.181
2021-12-29 2021-12-27 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -8.000 486.809
2021-12-29 2021-12-27 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,5833 -8.000 -117 144.036
2021-12-29 2021-12-27 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 8.000 47 152.036
2021-11-12 2021-11-11 4 Tregoning Kathleen SPRO Stock Option (right to buy) A - Award D 16,91 15.000 15.000
2021-11-02 2021-10-29 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 17,5345 150.000 2.630 4.713.688
2021-10-04 2021-09-30 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 18,6496 134.543 2.509 4.563.688
2021-09-15 2021-09-14 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 18,4937 2.156 40 4.429.145
2021-09-15 2021-09-13 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 18,5631 44.210 821 4.426.989
2021-09-10 2021-09-09 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 18,4974 24.749 458 4.382.779
2021-09-01 2021-08-31 4 Aquilo Capital Management, LLC See Footnotes. SPRO Common Stock, $0.001 par value P - Purchase I 18,9261 48.645 921 4.358.030
2021-09-01 2021-08-30 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 17,8661 44.042 787 4.309.385
2021-08-30 2021-08-26 4 Keutzer Timothy SPRO Common Stock A - Award D 24.067 26.567
2021-08-30 2021-08-26 4 JOSEPH TAMARA L SPRO Common Stock A - Award D 24.067 24.067
2021-08-30 2021-08-26 4 Larkin Cristina SPRO Common Stock A - Award D 24.067 25.567
2021-08-30 2021-08-26 4 Mahadevia Ankit SPRO Common Stock A - Award D 78.219 144.036
2021-08-30 2021-08-26 4 Melnick David A. SPRO Common Stock A - Award D 24.067 24.067
2021-08-30 2021-08-26 4 Shukla Sath SPRO Common Stock A - Award D 24.067 24.067
2021-08-27 2021-08-27 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 16,8755 13.957 236 4.265.343
2021-08-27 2021-08-26 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 16,5487 22.982 380 4.251.386
2021-08-24 2021-08-24 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 16,2757 40.170 654 4.228.404
2021-08-24 2021-08-23 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 16,3336 137.835 2.251 4.188.234
2021-08-24 2021-08-20 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 par value P - Purchase I 14,8601 221.190 3.287 4.050.399
2021-08-18 2021-08-17 4 Smith Cynthia SPRO Stock Option (right to buy) A - Award D 13,69 7.500 7.500
2021-08-18 2021-08-17 4 Pottage John C Jr SPRO Stock Option (right to buy) A - Award D 13,69 7.500 7.500
2021-08-18 2021-08-17 4 THOMAS FRANK E SPRO Stock Option (right to buy) A - Award D 13,69 7.500 7.500
2021-08-18 2021-08-17 4 Deshpande Milind SPRO Stock Option (right to buy) A - Award D 13,69 7.500 7.500
2021-08-18 2021-08-17 4 VINK PATRICK V.J.J. SPRO Stock Option (right to buy) A - Award D 13,69 7.500 7.500
2021-08-18 2021-08-17 4 Jackson Scott Thomas SPRO Stock Option (right to buy) A - Award D 13,69 7.500 7.500
2021-08-18 2021-08-17 4 FORMELA JEAN FRANCOIS SPRO Stock Option (right to buy) A - Award D 13,69 7.500 7.500
2021-02-10 2021-02-08 4 Aquilo Capital Management, LLC SPRO Common Stock, $0.001 Par Value S - Sale I 21,7384 -3.000 -65 3.829.209
2021-02-04 2021-02-04 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 Par Value S - Sale I 18,9859 -34.144 -648 3.832.209
2021-02-04 2021-02-03 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 Par Value S - Sale I 18,9787 -29.354 -557 3.866.353
2021-02-04 2021-02-02 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 Par Value S - Sale I 18,9909 -22.841 -434 3.895.707
2021-02-04 2021-02-01 4 Aquilo Capital Management, LLC See Footnotes SPRO Common Stock, $0.001 Par Value S - Sale I 19,2417 -13.661 -263 3.918.548
2021-02-03 2021-02-01 4 Keutzer Timothy SPRO Stock Option (Right to Buy) A - Award D 19,18 57.432 57.432
2021-02-03 2021-02-01 4 Larkin Cristina SPRO Stock Option (Right to Buy) A - Award D 19,18 57.432 57.432
2021-02-03 2021-02-01 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) A - Award D 19,18 179.319 179.319
2021-02-03 2021-02-01 4 Melnick David A. SPRO Stock Option (Right to Buy) A - Award D 19,18 57.432 57.432
2021-01-06 2021-01-04 4 VINK PATRICK V.J.J. SPRO Stock Option (right to buy) A - Award D 17,93 13,3100 1.314 17 1.314
2021-01-06 2021-01-04 4 THOMAS FRANK E SPRO Stock Option (right to buy) A - Award D 17,93 13,3100 1.314 17 1.314
2021-01-06 2021-01-04 4 Smith Cynthia SPRO Stock Option (right to buy) A - Award D 17,93 13,3100 2.629 35 2.629
2021-01-06 2021-01-04 4 Deshpande Milind SPRO Stock Option (right to buy) A - Award D 17,93 13,3100 2.629 35 2.629
2021-01-05 2021-01-04 4 Shukla Sath SPRO Stock Option (right to buy) A - Award D 17,93 75.000 75.000
2020-12-18 2020-12-17 4 Aquilo Capital Management, LLC See footnotes SPRO Common Stock, $0.001 par value S - Sale I 18,8129 -250.000 -4.703 3.932.209
2020-12-18 2020-12-16 4 Aquilo Capital Management, LLC See footnotes SPRO Common Stock, $0.001 par value S - Sale I 18,6188 -14.933 -278 4.182.209
2020-12-18 2020-12-16 4 Larkin Cristina SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -12.000 8.434
2020-12-18 2020-12-16 4 Larkin Cristina SPRO Common Stock S - Sale D 19,0000 -12.000 -228 1.500
2020-12-18 2020-12-16 4 Larkin Cristina SPRO Common Stock M - Exercise D 5,9000 12.000 71 13.500
2020-12-02 2020-12-02 4 JOSEPH TAMARA L SPRO Stock Option (right to buy) A - Award D 17,28 75.000 75.000
2020-11-10 2020-11-09 4 Aquilo Capital Management, LLC See footnotes SPRO Common Stock, $0.001 par value S - Sale I 13,7734 -125.900 -1.734 4.197.142
2020-11-06 2020-11-06 4 Aquilo Capital Management, LLC See footnotes SPRO Common Stock, $0.001 par value S - Sale I 13,7747 -5.000 -69 4.323.042
2020-11-06 2020-11-05 4 Aquilo Capital Management, LLC See footnotes SPRO Common Stock, $0.001 par value S - Sale I 13,9786 -96.600 -1.350 4.328.042
2020-11-06 2020-11-04 4 Aquilo Capital Management, LLC See footnotes SPRO Common Stock, $0.001 par value S - Sale I 14,2585 -72.500 -1.034 4.424.642
2020-11-05 2020-11-04 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -7.370 494.809
2020-11-05 2020-11-04 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,4281 -7.370 -106 65.817
2020-11-05 2020-11-04 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 7.370 43 73.187
2020-11-05 2020-11-03 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -2.137 502.179
2020-11-05 2020-11-03 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,2675 -2.137 -30 65.817
2020-11-05 2020-11-03 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 2.137 13 67.954
2020-10-27 2020-10-27 4 Jackson Scott Thomas SPRO Stock Option (right to buy) A - Award D 13,52 7.500 7.500
2020-10-27 2020-10-27 4 THOMAS FRANK E SPRO Stock Option (right to buy) A - Award D 13,52 7.500 7.500
2020-10-27 2020-10-27 4 Smith Cynthia SPRO Stock Option (right to buy) A - Award D 13,52 7.500 7.500
2020-10-27 2020-10-27 4 FORMELA JEAN FRANCOIS SPRO Stock Option (right to buy) A - Award D 13,52 7.500 7.500
2020-10-27 2020-10-27 4 Deshpande Milind SPRO Stock Option (right to buy) A - Award D 13,52 7.500 7.500
2020-10-27 2020-10-27 4 Pottage John C Jr SPRO Stock Option (right to buy) A - Award D 13,52 7.500 7.500
2020-10-27 2020-10-23 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -20 504.316
2020-10-27 2020-10-23 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,2500 -20 -0 65.817
2020-10-27 2020-10-23 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 20 0 65.837
2020-10-27 2020-10-27 4 VINK PATRICK V.J.J. SPRO Stock Option (right to buy) A - Award D 13,52 7.500 7.500
2020-10-15 2020-10-14 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -105 504.336
2020-10-15 2020-10-14 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,2500 -105 -1 65.817
2020-10-15 2020-10-14 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 105 1 65.922
2020-10-15 2020-10-13 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -14.367 504.441
2020-10-15 2020-10-13 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,2836 -14.367 -205 65.817
2020-10-15 2020-10-13 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 14.367 85 80.184
2020-09-22 3 Aquilo Capital, L.P. See Footnotes SPRO Common Stock, $0.001 Par Value I 4.497.142
2020-09-10 2020-09-08 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -774 518.808
2020-09-10 2020-09-08 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,2503 -774 -11 65.817
2020-09-10 2020-09-08 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 774 5 66.591
2020-07-09 2020-07-09 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -2.293 519.582
2020-07-09 2020-07-09 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,3073 -2.293 -33 65.817
2020-07-09 2020-07-09 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 2.293 14 68.110
2020-07-09 2020-07-07 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -754 521.875
2020-07-09 2020-07-07 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,2506 -754 -11 65.817
2020-07-09 2020-07-07 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 754 4 66.571
2020-06-29 2020-06-25 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -2.642 522.629
2020-06-29 2020-06-25 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,2507 -2.642 -38 65.817
2020-06-29 2020-06-25 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 2.642 16 68.459
2020-06-29 2020-06-24 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -3.880 525.271
2020-06-29 2020-06-24 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,2834 -3.880 -55 65.817
2020-06-29 2020-06-24 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 3.880 23 69.697
2020-06-29 2020-06-23 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -8.045 529.151
2020-06-29 2020-06-23 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,3274 -8.045 -115 65.817
2020-06-29 2020-06-23 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 8.045 47 73.862
2020-06-29 2020-06-22 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -2.613 537.196
2020-06-29 2020-06-22 4 Mahadevia Ankit SPRO Common Stock S - Sale D 14,2996 -2.613 -37 65.817
2020-06-29 2020-06-22 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 2.613 15 68.430
2020-06-23 2020-06-23 4 Jackson Scott Thomas SPRO Stock Option (right to buy) A - Award D 13,94 15.000 15.000
2020-02-03 2020-02-03 4 Keutzer Timothy SPRO Stock Option (Right to Buy) A - Award D 9,34 55.000 55.000
2020-02-03 2020-02-03 4 Larkin Cristina SPRO Stock Option (Right to Buy) A - Award D 9,34 55.000 55.000
2020-02-03 2020-02-03 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) A - Award D 9,34 180.000 180.000
2020-02-03 2020-02-03 4 Melnick David A. SPRO Stock Option (Right to Buy) A - Award D 9,34 55.000 55.000
2020-01-13 3 Keutzer Timothy SPRO Common Stock D 5.000
2020-01-13 3 Keutzer Timothy SPRO Common Stock D 5.000
2020-01-13 3 Keutzer Timothy SPRO Common Stock D 5.000
2020-01-06 2020-01-02 4 Deshpande Milind SPRO Stock Option (right to buy) A - Award D 9,87 6,4700 5.408 35 5.408
2020-01-06 2020-01-02 4 VINK PATRICK V.J.J. SPRO Stock Option (right to buy) A - Award D 9,87 6,4700 5.408 35 5.408
2020-01-06 2020-01-02 4 FORMELA JEAN FRANCOIS SPRO Stock Option (right to buy) A - Award D 9,87 6,4700 5.408 35 5.408
2020-01-06 2020-01-02 4 THOMAS FRANK E SPRO Stock Option (right to buy) A - Award D 9,87 6,4700 2.704 17 2.704
2019-06-05 2019-06-05 4 Deshpande Milind SPRO Stock Option (right to buy) A - Award D 10,67 6.073 6.073
2019-06-05 2019-06-05 4 FORMELA JEAN FRANCOIS SPRO Stock Option (right to buy) A - Award D 10,67 6.073 6.073
2019-06-05 2019-06-05 4 THOMAS FRANK E SPRO Stock Option (right to buy) A - Award D 10,67 6.073 6.073
2019-06-05 2019-06-05 4 Pottage John C Jr SPRO Stock Option (right to buy) A - Award D 10,67 6.073 6.073
2019-06-05 2019-06-05 4 Smith Cynthia SPRO Stock Option (right to buy) A - Award D 10,67 6.073 6.073
2019-06-05 2019-06-05 4 VINK PATRICK V.J.J. SPRO Stock Option (right to buy) A - Award D 10,67 6.073 6.073
2019-03-29 2019-03-29 4 Smith Cynthia SPRO Stock Option (right to buy) A - Award D 12,81 12.146 12.146
2019-01-02 2019-01-02 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) A - Award D 6,26 180.000 180.000
2019-01-02 2019-01-02 4 Sendek Joel SPRO Stock Option (Right to Buy A - Award D 6,26 65.000 65.000
2019-01-02 2019-01-02 4 Larkin Cristina SPRO Stock Option (Right to Buy) A - Award D 6,26 65.000 65.000
2019-01-02 2019-01-02 4 Melnick David A. SPRO Stock Option (Right to Buy) A - Award D 6,26 65.000 65.000
2019-01-02 2019-01-02 4 Parr Thomas R JR SPRO Stock Option (Right to Buy) A - Award D 6,26 35.000 35.000
2018-09-21 2018-09-21 4 Pottage John C Jr SPRO Stock Option (right to buy) A - Award D 10,25 12.146 12.146
2018-07-17 2018-07-17 4 GLAXOSMITHKLINE PLC By S.R. One, Limited SPRO Common Stock P - Purchase I 12,5000 80.000 1.000 1.934.006
2018-07-06 2018-07-06 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -1.600 118.888
2018-07-06 2018-07-06 4 Mahadevia Ankit SPRO Common Stock S - Sale D 17,9200 -200 -4 65.817
2018-07-06 2018-07-06 4 Mahadevia Ankit SPRO Common Stock S - Sale D 17,9000 -200 -4 66.017
2018-07-06 2018-07-06 4 Mahadevia Ankit SPRO Common Stock S - Sale D 17,7050 -100 -2 66.217
2018-07-06 2018-07-06 4 Mahadevia Ankit SPRO Common Stock S - Sale D 17,6200 -100 -2 66.317
2018-07-06 2018-07-06 4 Mahadevia Ankit SPRO Common Stock S - Sale D 17,5800 -400 -7 66.417
2018-07-06 2018-07-06 4 Mahadevia Ankit SPRO Common Stock S - Sale D 17,5450 -100 -2 66.817
2018-07-06 2018-07-06 4 Mahadevia Ankit SPRO Common Stock S - Sale D 17,5000 -500 -9 66.917
2018-07-06 2018-07-06 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 1.600 9 67.417
2018-07-06 2018-07-05 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -3.076 120.488
2018-07-06 2018-07-05 4 Mahadevia Ankit SPRO Common Stock S - Sale D 17,6215 -3.076 -54 65.817
2018-07-06 2018-07-05 4 Mahadevia Ankit SPRO Common Stock M - Exercise D 5,9000 3.076 18 68.893
2018-07-06 2018-07-05 4 Sendek Joel SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -2.000 165.833
2018-07-06 2018-07-05 4 Sendek Joel SPRO Common Stock S - Sale D 17,5000 -2.000 -35 15.181
2018-07-06 2018-07-05 4 Sendek Joel SPRO Common Stock M - Exercise D 5,9000 2.000 12 17.181
2018-07-06 2018-07-05 4 Larkin Cristina SPRO Stock Option (Right to Buy) M - Exercise D 5,90 -4.000 20.434
2018-07-06 2018-07-05 4 Larkin Cristina SPRO Common Stock S - Sale D 17,5000 -4.000 -70 1.500
2018-07-06 2018-07-05 4 Larkin Cristina SPRO Common Stock M - Exercise D 5,9000 4.000 24 5.500
2018-06-06 2018-06-05 4 VINK PATRICK V.J.J. SPRO Stock Option (right to buy) A - Award D 11,54 6.073 6.073
2018-06-06 2018-06-05 4 Deshpande Milind SPRO Stock Option (right to buy) A - Award D 11,54 6.073 6.073
2018-06-06 2018-06-05 4 Breum Casper SPRO Stock Option (right to buy) A - Award D 11,54 6.073 6.073
2018-06-06 2018-06-05 4 SOUTHWELL DAVID P SPRO Stock Option (right to buy) A - Award D 11,54 6.073 6.073
2018-06-06 2018-06-05 4 FORMELA JEAN FRANCOIS SPRO Stock Option (right to buy) A - Award D 11,54 6.073 6.073
2018-06-06 2018-06-05 4 THOMAS FRANK E SPRO Stock Option (right to buy) A - Award D 11,54 6.073 6.073
2018-03-30 2018-03-30 4 SOUTHWELL DAVID P SPRO Stock Option (right to buy) A - Award D 14,25 12.146 12.146
2018-01-05 2018-01-04 4 Melnick David A. SPRO Stock Option (Right to Buy) A - Award D 12,14 135.000 135.000
2017-12-15 2017-12-13 4 Mahadevia Ankit SPRO Stock Option (Right to Buy) A - Award D 11,63 125.079 125.079
2017-12-15 2017-12-13 4 Parr Thomas R JR SPRO Stock Option (Right to Buy) A - Award D 11,63 36.134 36.134
2017-12-15 2017-12-13 4 Sendek Joel SPRO Stock Option (Right to Buy) A - Award D 11,63 27.795 27.795
2017-12-15 2017-12-13 4 Larkin Cristina SPRO Stock Option (Right to Buy) A - Award D 11,63 62.540 62.540
2017-11-07 2017-11-06 4 GLAXOSMITHKLINE PLC SPRO Series C preferred stock C - Conversion I -3.683.045 0
2017-11-07 2017-11-06 4 GLAXOSMITHKLINE PLC SPRO Series B preferred stock C - Conversion I -1.250.000 0
2017-11-07 2017-11-06 4 GLAXOSMITHKLINE PLC SPRO Series A preferred stock C - Conversion I -982.906 0
2017-11-07 2017-11-06 4 GLAXOSMITHKLINE PLC SPRO Junior preferred stock C - Conversion I -1.483.784 0
2017-11-07 2017-11-06 4 GLAXOSMITHKLINE PLC SPRO Common Stock P - Purchase I 14,0000 428.571 6.000 1.854.006
2017-11-07 2017-11-06 4 GLAXOSMITHKLINE PLC SPRO Common Stock C - Conversion I 606.024 1.425.435
2017-11-07 2017-11-06 4 GLAXOSMITHKLINE PLC SPRO Common Stock C - Conversion I 328.992 819.411
2017-11-07 2017-11-06 4 GLAXOSMITHKLINE PLC SPRO Common Stock C - Conversion I 246.272 490.419
2017-11-07 2017-11-06 4 GLAXOSMITHKLINE PLC SPRO Common Stock C - Conversion I 244.147 244.147
2017-11-07 2017-11-06 4 Breum Casper Lundbeckfond Invest A/S SPRO Series C Preferred Stock C - Conversion I -2.485.272 0
2017-11-07 2017-11-06 4 Breum Casper Lundbeckfond Invest A/S SPRO Series B Preferred Stock C - Conversion I -681.818 0
2017-11-07 2017-11-06 4 Breum Casper Lundbeckfond Invest A/S SPRO Series A Preferred Stock C - Conversion I -1.153.846 0
2017-11-07 2017-11-06 4 Breum Casper Lundbeckfond Invest A/S SPRO Common Stock P - Purchase I 14,0000 214.285 3.000 1.091.774
2017-11-07 2017-11-06 4 Breum Casper Lundbeckfond Invest A/S SPRO Common Stock C - Conversion I 408.937 877.489
2017-11-07 2017-11-06 4 Breum Casper Lundbeckfond Invest A/S SPRO Common Stock C - Conversion I 179.450 468.552
2017-11-07 2017-11-06 4 Breum Casper Lundbeckfond Invest A/S SPRO Common Stock C - Conversion I 289.102 289.102
2017-11-07 2017-11-06 4 Larkin Cristina SPRO Common Stock P - Purchase D 14,0000 1.500 21 1.500
2017-11-07 2017-11-06 4 Sendek Joel Joel D. Sendek Retained Annuity Trust No. 1 SPRO Series C Preferred Stock C - Conversion I -61.880 0
2017-11-07 2017-11-06 4 Sendek Joel SPRO Common Stock P - Purchase D 14,0000 5.000 70 15.181
2017-11-07 2017-11-06 4 Sendek Joel Joel D. Sendek Retained Annuity Trust No. 1 SPRO Common Stock C - Conversion I 10.181 10.181
2017-11-07 2017-11-06 4 Goyal Vikas SPRO Series C preferred stock C - Conversion I -3.683.045 0
2017-11-07 2017-11-06 4 Goyal Vikas SPRO Series B preferred stock C - Conversion I -1.250.000 0
2017-11-07 2017-11-06 4 Goyal Vikas SPRO Series A preferred stock C - Conversion I -982.906 0
2017-11-07 2017-11-06 4 Goyal Vikas SPRO Junior preferred stock C - Conversion I -1.483.784 0
2017-11-07 2017-11-06 4 Goyal Vikas SPRO Common Stock P - Purchase I 14,0000 428.571 6.000 1.854.006
2017-11-07 2017-11-06 4 Goyal Vikas SPRO Common Stock C - Conversion I 606.024 1.425.435
2017-11-07 2017-11-06 4 Goyal Vikas SPRO Common Stock C - Conversion I 328.992 819.411
2017-11-07 2017-11-06 4 Goyal Vikas SPRO Common Stock C - Conversion I 246.272 490.419
2017-11-07 2017-11-06 4 Goyal Vikas SPRO Common Stock C - Conversion I 244.147 244.147
2017-11-07 2017-11-06 4 FORMELA JEAN FRANCOIS SPRO Series C Preferred Stock C - Conversion I -3.662.178 0
2017-11-07 2017-11-06 4 FORMELA JEAN FRANCOIS SPRO Series C Preferred Stock C - Conversion I -3.119.633 0
2017-11-07 2017-11-06 4 FORMELA JEAN FRANCOIS SPRO Series B Preferred Stock C - Conversion I -1.250.000 0
2017-11-07 2017-11-06 4 FORMELA JEAN FRANCOIS SPRO Series A Preferred Stock C - Conversion I -982.906 0
2017-11-07 2017-11-06 4 FORMELA JEAN FRANCOIS SPRO Junior Preferred Stock C - Conversion I -1.492.645 0
2017-11-07 2017-11-06 4 FORMELA JEAN FRANCOIS SPRO Common Stock P - Purchase I 14,0000 428.571 6.000 2.408.128
2017-11-07 2017-11-06 4 FORMELA JEAN FRANCOIS SPRO Common Stock C - Conversion I 602.589 1.979.557
2017-11-07 2017-11-06 4 FORMELA JEAN FRANCOIS SPRO Common Stock C - Conversion I 513.318 1.376.968
2017-11-07 2017-11-06 4 FORMELA JEAN FRANCOIS SPRO Common Stock C - Conversion I 328.992 863.650
2017-11-07 2017-11-06 4 FORMELA JEAN FRANCOIS SPRO Common Stock C - Conversion I 246.272 534.658
2017-11-07 2017-11-06 4 FORMELA JEAN FRANCOIS SPRO Common Stock C - Conversion I 245.605 288.386
2017-11-01 3 FORMELA JEAN FRANCOIS SPRO Common Stock I 85.562
2017-11-01 3 FORMELA JEAN FRANCOIS SPRO Common Stock I 85.562
2017-11-01 3 Mahadevia Ankit By Mahadevia-Mehta Family Trust SPRO Common Stock I 131.634
2017-11-01 3 Mahadevia Ankit By Mahadevia-Mehta Family Trust SPRO Common Stock I 131.634
2017-11-01 3 Atlas Venture Fund IX, L.P. SPRO Common Stock D 85.562
2017-11-01 3 Atlas Venture Fund IX, L.P. SPRO Common Stock D 85.562
2017-11-01 3 Atlas Venture Fund IX, L.P. SPRO Common Stock D 85.562
2017-11-01 3 Atlas Venture Fund IX, L.P. SPRO Common Stock D 85.562
2017-11-01 3 Deshpande Milind SPRO Common Stock D 32.908
2017-11-01 3 Deshpande Milind SPRO Common Stock D 32.908
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:2HA 2,41 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista